Preoperative Pericardial Effusion is Associated with Low Cardiac Output Syndrome After Pericardiectomy for Constrictive Pericarditis
Keywords:Preoperative pericardial effusion; low cardiac output syndrome; pericardiectomy.
Background: Low cardiac output syndrome is the main cause of death after pericardiectomy.
Methods: Patients who underwent pericardiectomy for constrictive pericarditis from January 2009 to October 2020 at our hospital were included in the study. Histopathologic studies of pericardium tissue from every patient were performed. All survivors were followed up.
Results: Ninety-two consecutive patients underdoing pericardiectomy were included in the study. The incidence of postoperative low cardiac output syndrome was 10.7% (10/92). There were five operative deaths. Mortality and incidence of LCOS in the group with pericardial effusion were significantly higher than those in the group without pericardial effusion. Tuberculosis of the pericardium (60/92, 65.2%) was the most common histopathologic finding in this study. Both univariate and multivariate analyses showed that preoperative pericardial effusion is associated with increased rate of low cardiac output syndrome. Eighty-five survivors were in NYHA class I (85/87, 97.7%), and two were in class II (2/87, 2.3%) at the latest follow up.
Conclusions: Preoperative pericardial effusion is associated with low cardiac output syndrome after pericardiectomy. Tuberculosis of the pericardium was the most common histopathologic finding in this study. For constrictive pericarditis caused by tuberculous bacteria, systematic antituberculosis drugs should be given. Preoperative pericardial effusion is associated with increased rate of low cardiac output syndrome. Perfect preoperative preparation is very important to reduce the incidence of postoperative low cardiac output syndrome and mortality. It is very important to use a large dose of diuretics with cardiotonic or vasopressor in a short time after the operation.
Acharya A, Koirala R, Rajbhandari N, et al. 2018. Anterior Pericardiectomy for Postinfective Constrictive Pericarditis: Intermediate-Term Outcomes. Ann Thorac Surg. 106(4):1178-1181.
Ahmad H, Porter R, Yusuff H, et al. 2019. Extracorporeal membrane oxygenation for right ventricular failure following pericardiectomy. Eur J Cardiothorac Surg. 56(3):625-626.
Bautista-Hernandez V, Karamanlidis G, McCully JD, et al. 2016. Cellular and Molecular Mechanisms of Low Cardiac Output Syndrome after Pediatric Cardiac Surgery. Curr Vasc Pharmacol. 14(1):5-13.
Calderon-Rojas R, Greason KL, King KS, et al. 2020. Tricuspid Valve Regurgitation in Patients Undergoing Pericardiectomy for Constrictive Pericarditis. Semin Thorac Cardiovasc Surg. S1043-0679(20)30052-6.
Cavigelli-Brunner A, Hug MI, Dave H, et al. 2018. Prevention of Low Cardiac Output Syndrome After Pediatric Cardiac Surgery: A Double-Blind Randomized Clinical Pilot Study Comparing Dobutamine and Milrinone. Pediatr Crit Care Med. 19(7):619-625.
Chandler HK, Kirsch R. 2016. Management of the Low Cardiac Output Syndrome Following Surgery for Congenital Heart Disease. Curr Cardiol Rev. 12(2):107-11.
Depboylu BC, Mootoosamy P, Vistarini N, et al. 2017. Surgical Treatment of Constrictive Pericarditis. Tex Heart Inst J. 44(2):101-106.
Du X, Chen H, Song X, et al. 2020. Risk factors for low cardiac output syndrome in children with congenital heart disease undergoing cardiac surgery: a retrospective cohort study. BMC Pediatr. 20(1):87.
Duncan AE, Kartashov A, Robinson SB, et al. 2020. Risk factors, resource use, and cost of postoperative low cardiac output syndrome. J Thorac Cardiovasc Surg. S0022-5223(20)32151-6.
Epting CL, McBride ME, Wald EL, et al. 2016. Pathophysiology of Post-Operative Low Cardiac Output Syndrome. Curr Vasc Pharmacol. 14(1):14-23.
Fang L, Yu G, Huang J, et al. 2020. Predictors of postoperative complication and prolonged intensive care unit stay after complete pericardiectomy in tuberculous constrictive pericarditis. J Cardiothorac Surg. 15(1):148.
Gatti G, Fiore A, Ternacle J, et al. 2020. Pericardiectomy for constrictive pericarditis: a risk factor analysis for early and late failure. Heart Vessels. 35(1):92-103.
Guerrero Orriach JL, Navarro Arce I, Hernandez Rodriguez P, et al. 2019. Preservation of renal function in cardiac surgery patients with low cardiac output syndrome: levosimendan vs beta agonists. BMC Anesthesiol. 19(1):212.
Lomivorotov VV, Efremov SM, Kirov MY, et al. 2017. Low-Cardiac-Output Syndrome After Cardiac Surgery. J Cardiothorac Vasc Anesth. 31(1):291-308.
Mehta RH, Leimberger JD, van Diepen S, et al. 2017. Levosimendan in Patients with Left Ventricular Dysfunction Undergoing Cardiac Surgery. N Engl J Med. 376(21):2032-2042.
Melo DTP, Nerbass FB, Sayegh ALC, et al. 2019. Impact of pericardiectomy on exercise capacity and sleep of patients with chronic constrictive pericarditis. PLoS One. 14(10):e0223838.
Mori M, Mullan CW, Bin Mahmood SU, et al. 2019. US National Trends in the Management and Outcomes of Constrictive Pericarditis: 2005-2014. Can J Cardiol. 35(10):1394-1399.
Rupprecht L, Putz C, Flörchinger B, et al. 2018. Pericardiectomy for Constrictive Pericarditis: An Institution's 21 Years Experience. Thorac Cardiovasc Surg. 66(8):645-650.
Thomas M, Kreibich M, Beyersdorf F, et al. 2020. Standardized Weaning from Temporary Extracorporeal Life Support in Cardiovascular Patients. Thorac Cardiovasc Surg. 68(5):425-432.
Vlasov H, Juvonen T, Hiippala S, et al. 2020. Effect and safety of 4% albumin in the treatment of cardiac surgery patients: study protocol for the randomized, double-blind, clinical ALBICS (ALBumin In Cardiac Surgery) trial. Trials. 21(1):235.
Wei S, Zhang L, Cui H, et al. 2019. Surgery for Patients with Radiation-Induced Constrictive Pericarditis. Heart Surg Forum. 22(6):E466-E469.
How to Cite
Author Disclosure & Copyright Transfer Agreement
In order to publish the original work of another person(s), The Heart Surgery Forum® must receive an acknowledgment of the Author Agreement and Copyright Transfer Statement transferring to Forum Multimedia Publishing, L.L.C., a subsidiary of Carden Jennings Publishing Co., Ltd. the exclusive rights to print and distribute the author(s) work in all media forms. Failure to check Copyright Transfer agreement box below will delay publication of the manuscript.
A current form follows:
The author(s) hereby transfer(s), assign(s), or otherwise convey(s) all copyright ownership of the manuscript submitted to Forum Multimedia Publishing, LLC (Publisher). The copyright transfer covers the exclusive rights to reproduce and distribute the article and the material contained therein throughout the world in all languages and in all media of expression now known or later developed, including but not limited to reprints, photographic reproduction, microfilm, electronic data processing (including programming, storage, and transmission to other electronic data record(s), or any other reproductions of similar nature), and translations.
However, Publisher grants back to the author(s) the following:
- The right to make and distribute copies of all or part of this work for use of the author(s) in teaching;
- The right to use, after publication in The Heart Surgery Forum, all or part of the material from this work in a book by the author(s), or in a collection of work by the author(s);
- The royalty-free right to make copies of this work for internal distribution within the institution/company that employs the author(s) subject to the provisions below for a work-made-for-hire;
- The right to use figures and tables from this work, and up to 250 words of text, for any purpose;
- The right to make oral presentations of material from this work.
Publisher reserves the right to grant or refuse permission to third parties to republish all or part of the article or translations thereof. To republish, such third parties must obtain written permission from the Publisher. (This is in accordance with the Copyright Statute, United States Code, Title 17. Exception: If all authors were bona fide officers or employees of the U.S. Government at the time the paper was prepared, the work is a “work of the US Government” (prepared by an officer or employee of the US Government as part of official duties), and therefore is not subject to US copyright; such exception should be indicated on signature lines. If this work was prepared under US Government contract or grant, the US Government may reproduce, royalty-free, all or portions of this work and may authorize others to do so, for official US Government purposes only, if the US Government contract or grant so requires.
I have participated in the conception and design of this work and in the writing of the manuscript and take public responsibility for it. Neither this manuscript nor one with substantially similar content under my authorship has been published, has been submitted for publication elsewhere, or will be submitted for publication elsewhere while under consideration by The Heart Surgery Forum, except as described in an attachment. I have reviewed this manuscript (original version) and approve its submission. If I am listed above as corresponding author, I will provide all authors with information regarding this manuscript and will obtain their approval before submitting any revision. I attest to the validity, accuracy, and legitimacy of the content of the manuscript and understand that Publisher assumes no responsibility for the validity, accuracy, and legitimacy of its content. I warrant that this manuscript is original with me and that I have full power to make this Agreement. I warrant that it contains no matter that is libelous or otherwise unlawful or that invades individual privacy or infringes any copyright or other proprietary right. I agree to indemnify and hold Publisher harmless of and from any claim made against Publisher that relates to or arises out of the publication of the manuscript and agree that this indemnification shall include payment of all costs and expenses relating to the defense of any such claim, including all reasonable attorney’s fees.
I warrant that I have no financial interest in the drugs, devices, or procedures described in the manuscript (except as disclosed in the attached statement).
I state that the institutional Human Subjects Committee and/or the Ethics Committee approved the clinical protocol reported in this manuscript for the use of experimental techniques, drugs, or devices in human subjects and appropriate informed consent documents were utilized.
Furthermore, I state that any and all animals used for experimental purposes received humane care in USDA registered facilities in compliance with the “Principles of Laboratory Animal Care” formulated by the National Society for Medical Research and the “Guide for the Care and Use of Laboratory Animals” prepared by the Institute of Laboratory Animal Resources and published by the National Institutes of Health (NIH Publication No. 85-23, revised 1985).